Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection
Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.
New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers
Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”
TAVR, other interventional procedures may provide value for patients with carcinoid heart disease
These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.
Cencora to buy nationwide oncology network in $5B deal
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
American College of Cardiology highlights the cardiovascular risks of various cancer treatments
The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection

Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.

Novel theranostic shows promise for treating gastric and pancreatic cancer

New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers

Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease

These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.

Cencora to buy nationwide oncology network in $5B deal

The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."

American College of Cardiology highlights the cardiovascular risks of various cancer treatments

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

Telix and Siemens Healthineers partner to advance oncologic therapies

Leaders from both companies are optimistic about how their partnership can improve precision medicine and palliative therapies.

AI spots more pancreatic cancer than radiologists

The use of artificial intelligence has the potential to significantly improve the diagnosis of pancreatic cancer, new data suggest.

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients

The positive findings come after the U.S. Food and Drug Administration previously shared concerns related to sterility assurance issues during the drug’s production.